Suitors for Pfizer's consumer healthcare unit vanish
Pfizer’s consumer healthcare business has gone from being the belle of the ball to the last one left on the dancefloor on Friday, after GlaxoSmithKline joined Reckitt Benckiser in pulling out of a potential acquisition of the unit.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts